Distinct classes of gut bacterial molybdenum-dependent enzymes produce urolithins
Proceedings of the National Academy of Sciences · 30.12.2025 · 122 (52)
DOI: 10.1073/pnas.2501312122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 24.12.2025. Verfasst von Minwoo Bae und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Coumarins, Molybdenum, Bacteria. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NSF (NSF), Biocodex Microbiota Foundation (BMF), HHMI (HHMI).
Abstract (Originalsprache)
Urolithin A is an anti-aging and anti-inflammatory gut bacterial metabolite derived from ellagic acid (EA), a polyphenol abundant in berries and nuts. The conversion of EA to urolithin A involves multiple chemically challenging phenol dehydroxylation steps that produce urolithins with varying bioactivities. Despite their biological and chemical significance, the bacterial enzymes responsible for urolithin production remain largely unidentified. Here, we use differential gene expression analysis, anaerobic protein production, and enzyme assays to identify members of two distinct molybdenum enzyme families (the DMSO reductase family and the xanthine oxidase family) capable of regioselective dehydroxylation and urolithin generation. These two enzyme families have distinct substrate requirements, suggesting they employ different catalytic mechanisms for phenol dehydroxylation. Multiomics analysis of a human cohort uncovers decreased levels of urolithin A and genes encoding urolithin A-producing enzymes in patients with inflammatory bowel disease (IBD), implying reduced health effects of EA consumption in this setting. Together, this study elucidates the molecular basis of urolithin production, expands the known enzymatic repertoire of the human gut microbiome, and suggests a potential link between gut bacterial urolithin production and reduced host inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138.
- Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.
- HHMI, Harvard University, Cambridge, MA 02138.
ORCID-Profile: Minwoo Bae, Xueyang Dong, Julian Avila-Pacheco, Quyen D Nguyen, Fechi Inyama, Emily P Balskus
Förderung
- NSF (NSF)
- Biocodex Microbiota Foundation (BMF)
- HHMI (HHMI)
- Kwanjeong Educational Foundation (KEF)
Zitieren
APA
Bae, M., Dong, X., Avila-Pacheco, J., Nguyen, Q. D., Inyama, F., Hill-Maini, V., Clish, C. B., & Balskus, E. P. (2025). Distinct classes of gut bacterial molybdenum-dependent enzymes produce urolithins. Proceedings of the National Academy of Sciences, 122(52). https://doi.org/10.1073/pnas.2501312122
Vancouver
Bae M, Dong X, Avila-Pacheco J, Nguyen QD, Inyama F, Hill-Maini V, et al. Distinct classes of gut bacterial molybdenum-dependent enzymes produce urolithins. Proceedings of the National Academy of Sciences. 2025;122(52). doi:10.1073/pnas.2501312122
BibTeX
@article{Bae2025,
author = {Bae, Minwoo and Dong, Xueyang and Avila-Pacheco, Julian and Nguyen, Quyen D and Inyama, Fechi and Hill-Maini, Vayu and Clish, Clary B and Balskus, Emily P},
title = {Distinct classes of gut bacterial molybdenum-dependent enzymes produce urolithins},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {52},
doi = {10.1073/pnas.2501312122}
}
EUVIMED